Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection.
about
Cryoelectron tomography of HIV-1 envelope spikes: further evidence for tripod-like legsHIV-1 cell to cell transfer across an Env-induced, actin-dependent synapseActin-binding protein drebrin regulates HIV-1-triggered actin polymerization and viral infectioncis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptorHistone deacetylase 6 regulates human immunodeficiency virus type 1 infectionPhosphatidylinositol 3-kinase regulates human immunodeficiency virus type 1 replication following viral entry in primary CD4+ T lymphocytes and macrophagesDC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in transHIV type 1 Gag as a target for antiviral therapyCCR5 Targeted Cell Therapy for HIV and Prevention of Viral EscapeHIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategiesDiverse CD81 Proteins Support Hepatitis C Virus InfectionLipids and membrane microdomains in HIV-1 replicationThe role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination?Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy.The PDZ-adaptor protein syntenin-1 regulates HIV-1 entryBroadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cellsAnalysis of the subunit stoichiometries in viral entry.Anti-HIV agents targeting the interaction of gp120 with the cellular CD4 receptor.Novel approaches to inhibiting HIV-1 replication.Covalent conjugation of a peptide triazole to HIV-1 gp120 enables intramolecular binding site occupancyThermal stability of the human immunodeficiency virus type 1 (HIV-1) receptors, CD4 and CXCR4, reconstituted in proteoliposomes.Genetic variation and HIV-associated neurologic disease.Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor.Antigenic variation within the CD4 binding site of human immunodeficiency virus type 1 gp120: effects on chemokine receptor utilization.Molecular basis for cell tropism of CXCR4-dependent human immunodeficiency virus type 1 isolatesMacrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity.CD4-independent use of Rhesus CCR5 by human immunodeficiency virus Type 2 implicates an electrostatic interaction between the CCR5 N terminus and the gp120 C4 domain.HIV envelope gp120 activates human arterial smooth muscle cells.Kinetic rates of antibody binding correlate with neutralization sensitivity of variant simian immunodeficiency virus strainsHIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies.Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins.Envelope is a major viral determinant of the distinct in vitro cellular transformation tropism of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2.Similar regulation of cell surface human T-cell leukemia virus type 1 (HTLV-1) surface binding proteins in cells highly and poorly transduced by HTLV-1-pseudotyped virionsInhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virusStabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.Constitutively active CCR5 chemokine receptors differ in mediating HIV envelope-dependent fusion.Attachment and fusion inhibitors potently prevent dendritic cell-driven HIV infectionThirty years on: HIV receptor gymnastics and the prevention of infection
P2860
Q21090520-B01AC1E8-A021-4B82-BD98-BD7FC779414BQ22242967-81A66636-4A2E-4C87-9AA4-7A3CEAE8784CQ24316027-8139BF2E-B975-40BE-93A3-BE7EFBE26C16Q24530658-6B6AF054-B277-4BA7-91A6-C15A5A75776AQ24535531-A20112FD-CD66-47F5-BE26-19D1B07B8824Q24541375-32FED602-39EC-45FE-B7FC-9FC23ADA86D3Q24601035-324519DA-0C32-44AE-B9E3-0110654B0DA2Q24614498-A24FE3C1-6DB0-4186-B39F-A4EBC35297A5Q26801498-23F563B8-E1A1-444F-B219-FF49D782C2EFQ26825087-40CAF297-AA0C-40D7-BCCD-72F34DA2DD04Q27477625-85F15B3D-D3AF-4A6E-AB63-2378D57806F4Q27489393-4B288D33-3DF2-4540-9EBC-E6E0406F9FBAQ28201093-413F688E-70F0-4D4D-9A9B-DDB04455FEFEQ30489853-D4CCC0B9-EAC0-4D22-8C07-F2AD526F152DQ30515961-21B0329A-3544-4FEB-A88C-B7F6C390141EQ30706865-35831503-9433-4586-A56F-97A96B3D4224Q30865013-BCC55F3B-6EE4-483F-B858-3868533B99B1Q31053897-F9D18191-48C8-4B0C-B3A2-536FBA8A25E0Q33223969-4A50B30B-0737-4E93-BDF8-A4FA6975B263Q33624690-6856E059-8843-4AEB-84C8-C6DB47CCF851Q33710476-F1733EDA-73A0-42DB-A895-B8406FC4EFF3Q33725587-8A31815B-54A2-487E-B4F9-AAFF7A9CC553Q33819189-5B73FE97-67AA-468D-A4BD-B60CF6C2A96AQ33840312-71255891-C4F9-4DD6-B974-F82AAE64E712Q33841969-004F8BEE-2C2A-492F-AFD0-E8AC0DF269A6Q33844079-9BEDD23D-C1DF-44FD-ACAA-44EE0C427625Q33847458-132EA3BE-5E2A-469C-871F-EE5E8BEEA537Q33848876-E7623C8B-378E-4640-B245-739E44901895Q33943009-B17DDBDD-F419-49F4-8E26-B9D0F9D46218Q33984358-CCE7D7B9-BE3D-4FBE-855B-728C0CFCCF80Q34001144-1955315E-61F4-4509-BD06-E92A1913B8D2Q34010373-46BE5265-1934-451D-B681-04A7AD22735CQ34142780-5CBBB892-B71D-4197-A6AF-A298F7240067Q34354324-182DAEF4-521E-42C1-A625-BFF8FA286E94Q34354703-EDE6714B-B1F1-40EF-8169-84FA86107307Q34361680-221C9068-0B26-4BE4-9341-05DCFE724B2EQ34464860-278C5C4C-AF93-4FDB-BCDB-F1E216B535E2Q34565057-46F8CD01-8D9C-49CB-81F4-E078D7ED50ECQ34574462-F9A97D08-A004-4B85-AFB6-61BD6365AC49Q34732816-16D8D594-DAB4-4A08-9E30-9A4064D09134
P2860
Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Beyond receptor expression: th ...... d affinity in HIV-1 infection.
@ast
Beyond receptor expression: th ...... d affinity in HIV-1 infection.
@en
Beyond receptor expression: th ...... d affinity in HIV-1 infection.
@nl
type
label
Beyond receptor expression: th ...... d affinity in HIV-1 infection.
@ast
Beyond receptor expression: th ...... d affinity in HIV-1 infection.
@en
Beyond receptor expression: th ...... d affinity in HIV-1 infection.
@nl
prefLabel
Beyond receptor expression: th ...... d affinity in HIV-1 infection.
@ast
Beyond receptor expression: th ...... d affinity in HIV-1 infection.
@en
Beyond receptor expression: th ...... d affinity in HIV-1 infection.
@nl
P356
P1433
P1476
Beyond receptor expression: th ...... d affinity in HIV-1 infection.
@en
P2093
P304
P356
10.1006/VIRO.2000.0612
P407
P577
2000-10-01T00:00:00Z